Fumaric Acid

Fumaric Acid

SCHEMBL6494416

N#Cc1ccc(Cl)cc1S[C@H](CCN)c1ccccc1.O=C(O)/C=C/C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 10/20 1.00
SLC6A4 known ✓ P31645 10/20 1.00
KCNH2 known ✓ Q12809 2/20 0.37
MEN1 known ✓ O00255 1/20 0.34
KMT2A known ✓ Q03164 1/20 0.34
NOS2 P35228 13/20 1.00
CYP2D6 P10635 10/20 1.00
S1PR3 Q99500 1/20 0.35
LMNA P02545 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
BLM P54132 1/20 0.34
PMP22 Q01453 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ITGB2 P05107 1/20 0.34
ICAM1 P05362 1/20 0.34
ITGAL P20701 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6494424 1.00 NOS2 (1.00) NOS2CYP2D6SLC6A2SLC6A4KCNH2
SCHEMBL6505773 0.91 NOS2 (1.00) NOS2CYP2D6SLC6A2SLC6A4KCNH2
Fumaric Acid SCHEMBL6504307 0.85 NOS2 (0.74) NOS2CYP2D6SLC6A2SLC6A4KCNH2
Fumaric Acid SCHEMBL6504303 0.85 NOS2 (0.74) NOS2CYP2D6SLC6A2SLC6A4KCNH2
SCHEMBL5653417 0.81 NOS2 (0.81) NOS2CYP2D6SLC6A2SLC6A4KCNH2
Hydrochloric Acid SCHEMBL5652171 0.81 NOS2 (0.79) NOS2CYP2D6SLC6A2SLC6A4KCNH2
SCHEMBL6494143 0.77 SLC6A4 (0.72) NOS2CYP2D6SLC6A2SLC6A4KCNH2
Hydrochloric Acid SCHEMBL6496956 0.76 SLC6A4 (0.71) NOS2CYP2D6SLC6A2SLC6A4KCNH2
SCHEMBL6495015 0.75 SLC6A2 (0.70) NOS2CYP2D6SLC6A2SLC6A4KCNH2
SCHEMBL5648745 0.75 SLC6A2 (0.70) NOS2CYP2D6SLC6A2SLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953797-B2 Use of phenylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2005-10-11 US disclosed
US-20030073685-A1 Novel use of phenylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073685-A1 Novel use of phenylheteroalkylamine derivatives CYP1A1, CYP1A2, CYP2E1 SLC6A2 1769/4885SLC6A4 1977/4885KCNH2 1824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.